167 related articles for article (PubMed ID: 28823270)
21. Prognostic Relevance of Concordant Expression CD69 and CD56 in Response to Bortezomib Combination Therapy in Multiple Myeloma Patients.
ElMenshawy N; Farag NA; Atia DM; Abousamra N; Shahin D; Fawzi E; Ghazi H; El-Kott AF; Eissa M
Cancer Invest; 2021 Oct; 39(9):777-782. PubMed ID: 34344244
[TBL] [Abstract][Full Text] [Related]
22. The role of CD19 and CD27 in the diagnosis of multiple myeloma by flow cytometry: a new statistical model.
Cannizzo E; Carulli G; Del Vecchio L; Ottaviano V; Bellio E; Zenari E; Azzarà A; Petrini M; Preffer F
Am J Clin Pathol; 2012 Mar; 137(3):377-86. PubMed ID: 22338049
[TBL] [Abstract][Full Text] [Related]
23. Accuracy of Bone Marrow Flow Cytometry Analysis in Patients With Plasma Cell Neoplasm in Thailand: A Single Institutional Study.
Limvorapitak W; Srisum-Ang T; Chimres C; Warnnissorn N; Kanitsap N
Clin Lymphoma Myeloma Leuk; 2016 Mar; 16(3):e27-37. PubMed ID: 26796980
[TBL] [Abstract][Full Text] [Related]
24. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
Kim D; Park CY; Medeiros BC; Weissman IL
Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
[TBL] [Abstract][Full Text] [Related]
25. Inability of a monoclonal anti-light chain antibody to detect clonal plasma cells in a patient with multiple myeloma by multicolor flow cytometry.
van Velzen JF; van den Blink D; Bloem AC
Cytometry B Clin Cytom; 2013; 84(1):30-2. PubMed ID: 23019187
[TBL] [Abstract][Full Text] [Related]
26. Immunophenotypic analysis of abnormal plasma cell clones in bone marrow of primary systemic light chain amyloidosis patients.
Hu Y; Wang M; Chen Y; Chen X; Fang F; Liu S; Zhang Y; Wu X; Zhu P
Chin Med J (Engl); 2014; 127(15):2765-70. PubMed ID: 25146610
[TBL] [Abstract][Full Text] [Related]
27. CD20-negative low-grade B cell lymphoma showing immunophenotypic and genotypic features resembling plasma cell myeloma.
Tabata R; Yasumizu R; Tabata C; Kojima M
Pathol Res Pract; 2013 Jul; 209(7):459-62. PubMed ID: 23707547
[TBL] [Abstract][Full Text] [Related]
28. Antigen Expression Patterns of Plasma Cell Myeloma: An Association of Cytogenetic Abnormality and International Staging System (ISS) for Myeloma.
Shin SY; Lee ST; Kim HJ; Kim SJ; Kim K; Kang ES; Kim SH
J Clin Lab Anal; 2015 Nov; 29(6):505-10. PubMed ID: 25277787
[TBL] [Abstract][Full Text] [Related]
29. [Application of CD138 Immunomagnetic Sorting Myeloma Cells Combined with Fluorescence in Situ Hybridization for Detecting Cytogenetic Abnormalities of Multiple Myeloma].
Gao L; Liu Q; Shi Y; Dang H; He Q; Wang Z; Feng L; Li Y; Wang XY; Li N; Song WJ; Wang YL; Kong S; Lu J; Huang XJ; Lai YY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):807-812. PubMed ID: 28641640
[TBL] [Abstract][Full Text] [Related]
30. [The Significance of CD319 and CD269 in the Detection of Immunophenotyping and Minimal Residual Disease in Multiple Myeloma Patients].
Chu B; Wang YT; Lu MQ; Shi L; Gao S; Fang LJ; Xiang QQ; Bao L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1195-1202. PubMed ID: 34362502
[TBL] [Abstract][Full Text] [Related]
31. Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma.
Bae MH; Park CJ; Kim BH; Cho YU; Jang S; Lee DH; Seo EJ; Yoon DH; Lee JH; Suh C
Cytometry B Clin Cytom; 2018 May; 94(3):493-499. PubMed ID: 29220877
[TBL] [Abstract][Full Text] [Related]
32. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
[TBL] [Abstract][Full Text] [Related]
33. In multiple myeloma clonotypic CD38- /CD19+ / CD27+ memory B cells recirculate through bone marrow, peripheral blood and lymph nodes.
Rasmussen T; Lodahl M; Hancke S; Johnsen HE
Leuk Lymphoma; 2004 Jul; 45(7):1413-7. PubMed ID: 15359642
[TBL] [Abstract][Full Text] [Related]
34. [Immunophenotype characteristics in multiple myeloma cells and their significance].
Sun Y; Fang MY; Liu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):381-4. PubMed ID: 20416173
[TBL] [Abstract][Full Text] [Related]
35. Immunophenotypic Heterogeneity of Polytypic Plasma Cells and the Impact on Myeloma Minimal Residual Disease Detection by Multiparameter Flow Cytometry.
Schouweiler KE; Karandikar NJ; Holman CJ
Cytometry B Clin Cytom; 2019 Jul; 96(4):310-318. PubMed ID: 31140731
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma.
Lin P; Owens R; Tricot G; Wilson CS
Am J Clin Pathol; 2004 Apr; 121(4):482-8. PubMed ID: 15080299
[TBL] [Abstract][Full Text] [Related]
37. Development of an unbiased, semi-automated approach for classifying plasma cell immunophenotype following multicolor flow cytometry of bone marrow aspirates.
Post SR; Post GR; Nikolic D; Owens R; Insuasti-Beltran G
Cytometry B Clin Cytom; 2018 Sep; 94(5):602-610. PubMed ID: 29573142
[TBL] [Abstract][Full Text] [Related]
38. [Study on molecular cytogenetic abnormalities in multiple myeloma].
Liu SY; Li JY; Chen LJ; Huang JW; Pan JL; Qiu HR; Shen YF; Xu W; Xue YQ
Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):223-6. PubMed ID: 17877196
[TBL] [Abstract][Full Text] [Related]
39. Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage.
Rawstron AC; Owen RG; Davies FE; Johnson RJ; Jones RA; Richards SJ; Evans PA; Child JA; Smith GM; Jack AS; Morgan GJ
Br J Haematol; 1997 Apr; 97(1):46-55. PubMed ID: 9136941
[TBL] [Abstract][Full Text] [Related]
40. [Immunophenotypic characteristics of multiple myeloma cells].
Li JL; Liu YR; Chang Y; Fu JY; Chen SS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):226-8. PubMed ID: 12513791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
